Dr. Marik spoke last week at the UW Medicine Pacific Northwest Sepsis
Conference on "The Cure for Sepsis" and "Fluid Management of Hemodynamic
Assessment." He gave very interesting and popular talks, and I'm
recommending to the planning committee that he come back for next year's
conference.

 

Amanda Sigala RN, BSN, MPH

Clinical Quality Specialist

Quality Improvement

Harborview Medical Center

Box 359731

325 Ninth Avenue

Seattle, WA 98104

Phone: 206-744-9433

[email protected]

 

 

This message and any attachments to it is protected by coordinated quality
improvement/risk management/peer review confidentiality under RCW
70.41.200/4.24.250/43.70.510.  Privileged confidential patient identifiable
information also may be contained in this message.  This information is
meant only for the use of the intended recipients.  If you are not the
intended recipient or if the message has been addressed to you in error, do
not read, disclose, reproduce, distribute, disseminate or otherwise use this
transmission. Instead, please notify the sender by reply email and then
destroy all copies of the message and any attachments.

 

The above email may contain patient identifiable or confidential
information. Because email is not secure, please be aware of associated
risks of email transmission. If you are a patient, communicating to a UW
Medicine Provider via email implies your agreement to email communication;
see http://www.uwmedicine.org/Global/Compliance/EmailRisk.htm

 

The information is intended for the individual named above. If you are not
the intended recipient, any disclosure, copying, distribution or use of the
contents of this information is prohibited.  Please notify the sender by
reply email, and then destroy all copies of the message and any attachments.
See our Notice of Privacy Practices at www.uwmedicine.org

 

 

-----Original Message-----
From: [email protected]
[mailto:[email protected]] 
Sent: Thursday, March 23, 2017 2:52 PM
To: [email protected]
Subject: [Sepsis Groups] Potential new treatments for sepsis being studied

 

 
<http://www.npr.org/sections/health-shots/2017/03/23/521096488/doctor-turns-
up-possible-treatment-for-deadly-sepsis>
http://www.npr.org/sections/health-shots/2017/03/23/521096488/doctor-turns-u
p-possible-treatment-for-deadly-sepsis

 

This was very interesting.  Looking forward to the completed study to see if
it works out as a viable treatment. 

 

Lucinda Rosebush, RN, BSN 

Sepsis Coordinator 

Capital Regional Medical Center

Tallahassee, Florida 

 <mailto:[email protected]>
[email protected]  

 

-----Original Message-----

From: Sepsisgroups [ <mailto:[email protected]>
mailto:[email protected]] On Behalf Of
<mailto:[email protected]>
[email protected]

Sent: Monday, March 13, 2017 5:20 PM

To:  <mailto:[email protected]>
[email protected]

Subject: [EXTERNAL] Sepsisgroups Digest, Vol 238, Issue 5

 

Send Sepsisgroups mailing list submissions to

                 <mailto:[email protected]>
[email protected]

 

To subscribe or unsubscribe via the World Wide Web, visit

 
<http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org>
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org

 

or, via email, send a message with subject or body 'help' to

                 <mailto:[email protected]>
[email protected]

 

You can reach the person managing the list at

                 <mailto:[email protected]>
[email protected]

 

When replying, please edit your Subject line so it is more specific than
"Re: Contents of Sepsisgroups digest..."

 

 

Today's Topics:

 

   1. Re: Antibiotics >24 prior to presentation of Sepsis

      (DHILLON, ROOPINDER)

 

 

----------------------------------------------------------------------

 

Message: 1

Date: Thu, 9 Mar 2017 17:43:38 +0000

From: "DHILLON, ROOPINDER" < <mailto:[email protected]>
[email protected]>

To: "'Cynthia Wells'" < <mailto:[email protected]>
[email protected]>, "Pender.Linda"

                < <mailto:[email protected]>
[email protected]>,

                " <mailto:[email protected]>
[email protected]"

                < <mailto:[email protected]>
[email protected]>

Subject: Re: [Sepsis Groups] Antibiotics >24 prior to presentation of

                Sepsis

Message-ID:

                <
<mailto:[email protected]>
[email protected]>

Content-Type: text/plain; charset="us-ascii"

 

Agree. CMS needs to make the changes soon and we should be allowed to
reabstract.

 

From: Sepsisgroups [ <mailto:[email protected]>
mailto:[email protected]] On Behalf Of Cynthia
Wells

Sent: Wednesday, March 08, 2017 1:03 PM

To: Pender.Linda;  <mailto:[email protected]>
[email protected]

Subject: Re: [Sepsis Groups] Antibiotics >24 prior to presentation of Sepsis

 

Hi,

 

When CMS redid the algorithim-specifications in July they made an error with
the algorithm so that Lactate comes before Antibiotics. I brought this to
their attention in the fall and they have yet to make that change even
though it is still in the measure definitions that these patients are
supposed to be excluded. They are not excluded until a lactate is drawn.. if
one isn't drawn it is an outlier.

 

Cindy

 

Cynthia Wells

Steward Health Care

Director of Clinical Performance Analytics

(508) 404-8647

 

From: Sepsisgroups [ <mailto:[email protected]>
mailto:[email protected]] On Behalf Of
Pender.Linda

Sent: Friday, March 03, 2017 12:12 PM

To:
<mailto:[email protected]%3cmailto:[email protected]
isgroups.org>
[email protected]<mailto:[email protected]
rg>

Subject: [Sepsis Groups] Antibiotics >24 prior to presentation of Sepsis

 

If a patient is on IV antibiotics for >24 hours prior severe sepsis
presentation shouldn't they be excluded from the Sep-1 Core Measure? We use
Comparion to abstract our data. The abstracting tool requires entry of the
initial collection of the lactic acid before the antibiotics, if the patient
did not have a lactic acid collected 6 hrs before of 3 hrs after the severe
sepsis presentation, the pt fails the measure instead of being excluded.

Please let me know what you all think of this. It is truly affecting our
numbers.

 

Linda G. Pender RRT-NPS

Sepsis Coordinator

Patient Care Services  Administration

phone: 478-633-6806  pager: 4444

KNOW Sepsis: Inside & Out

[MCCG...World Class Care!  See our website...]<
<http://www.navicenthealth.org/> http://www.navicenthealth.org/>

Confidential Quality Improvement: Not for Disclosure

Email:
<mailto:[email protected]%3cmailto:Pender.Linda@NavicentHealth
.org>
[email protected]<mailto:[email protected]>

 

CONFIDENTIALITY NOTICE: The information transmitted in this e-mail message,
including any attachments, is for the sole use of the intended recipient(s)
or entity to which it is addressed and may contain confidential, privileged,
and/or proprietary information. Any unauthorized review, retransmission,
use, disclosure, dissemination, or other use of, or taking any action in
reliance upon this information by persons or entities other than the
intended recipient is prohibited. If you are not the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying,
or other use of this message or its attachments is strictly prohibited. If
you have received this message in error, please notify the sender
immediately by reply e-mail, or by calling (478) 633-7272, and destroy the
original message, attachments, and all copies thereof on all computers and
in any other form. Thank you. Navicent Health.
<http://www.navicenthealth.org/> http://www.navicenthealth.org/ Visit us at
<http://www.UHhospitals.org> www.UHhospitals.org.

 

The enclosed information is STRICTLY CONFIDENTIAL and is intended for the
use of the addressee only. University Hospitals and its affiliates disclaim
any responsibility for unauthorized disclosure of this information to anyone
other than the addressee.

 

Federal and Ohio law protect patient medical information, including
psychiatric_disorders, (H.I.V) test results, A.I.Ds-related conditions,
alcohol, and/or drug_dependence or abuse disclosed in this email. Federal
regulation (42 CFR Part 2) and Ohio Revised Code section 5122.31 and

3701.243 prohibit disclosure of this information without the specific
written consent of the person to whom it pertains, or as otherwise permitted
by law.

-------------- next part --------------

An HTML attachment was scrubbed...

URL: <
<http://lists.sepsisgroups.org/pipermail/sepsisgroups-sepsisgroups.org/attac
hments/20170309/3de6f6a8/attachment.htm>
http://lists.sepsisgroups.org/pipermail/sepsisgroups-sepsisgroups.org/attach
ments/20170309/3de6f6a8/attachment.htm>

-------------- next part --------------

A non-text attachment was scrubbed...

Name: image001.png

Type: image/png

Size: 9451 bytes

Desc: image001.png

URL: <
<http://lists.sepsisgroups.org/pipermail/sepsisgroups-sepsisgroups.org/attac
hments/20170309/3de6f6a8/attachment.png>
http://lists.sepsisgroups.org/pipermail/sepsisgroups-sepsisgroups.org/attach
ments/20170309/3de6f6a8/attachment.png>

 

------------------------------

 

Subject: Digest Footer

 

_______________________________________________

Sepsisgroups mailing list

 <mailto:[email protected]>
[email protected]

 <http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org>
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org

 

 

------------------------------

 

End of Sepsisgroups Digest, Vol 238, Issue 5

********************************************

 

 

_______________________________________________
Sepsisgroups mailing list
[email protected]
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org

Reply via email to